Enterococcus faecium

Antibiotic
% Susceptible
2010
% Susceptible
2012
% Susceptible
2014
% Susceptible
2016
% Susceptible
2018
Ampicillin
37
50 34 66 45
Azithromycin
-
-
-
- -
Aztreonam
-
-
-
- -
Cefazolin
-
-
-
- -
Cefepime
-
-
-
- -
Ceftazidime
-
-
-
- -
Ceftriaxone
-
-
-
- -
Cefuroxime
-
-
-
- -
Ciprofloxacin
20
31
20
24 25
Clarithromycin
-
-
-
- -
Clindamycin
-
-
-
- -
Doxycycline
63
61
59
38 41
Erythromycin
-
-
-
- -
Gentamicin
63S
96S
82S
91S 96S
Imipenem
+/-
+/-
+/-
+/- +/-
Levofloxacin 27 43 28 29 29
Meropenem - - - - -
Moxifloxacin +/- +/- +/- +/- +/-
Nitrofurantoin 58& 65& 45& 50& 53&
Oxacillin/Naf - - - - -
Penicillin 35 50 32 66 43
Piperacillin +/- +/- +/- +/- +/-
Piperacillin/tazo +/- +/- +/- +/- +/-
Ticarcillin/Clav -* -* -* -* -*
Tobramycin - - - - -
TMP/SMX - - - - -
Unasyn/Aug
Vancomycin 53 70 51 56 63
       
# Tested 66 54 99 66 51

Comments:  

 

Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections